We are live on ! Find out more
ANIP icon

ANI Pharmaceuticals
ANIP

232 hedge funds and large institutions have $1.29B invested in ANI Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 89 increasing their positions, 76 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more call options, than puts

Call options by funds: $1.37M | Put options by funds: $874K

17% more repeat investments, than reductions

Existing positions increased: 89 | Existing positions reduced: 76

12% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 25

1% more funds holding

Funds holding: 230 → 232 (+2)

0.84% less ownership

Funds ownership: 92.01% → 91.17% (-0.84%)

5% less capital invested

Capital invested by funds: $1.35B → $1.29B (-$63.9M)

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

Holders
232
Holders Change
+2
Holders Change %
+0.87%
% of All Funds
3.05%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
28
Increased
89
Reduced
76
Closed
25
Calls
$1.37M
Puts
$874K
Net Calls
+$496K
Net Calls Change
+$824K

Top Buyers

Rank Fund Capital Flow
1
N
Nuveen
North Carolina
+$21M
2
RCMNY
Rubric Capital Management (New York)
New York
+$13.1M
3
FGP
Freestone Grove Partners
California
+$12.4M
4
Millennium Management
Millennium Management
New York
+$12.1M
5
Teacher Retirement System of Texas
Teacher Retirement System of Texas
Texas
+$9.3M

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$27.7M
2
Morgan Stanley
Morgan Stanley
New York
-$15.4M
3
SCM
Soleus Capital Management
Connecticut
-$11.3M
4
Nomura Holdings
Nomura Holdings
Japan
-$11.3M
5
WP
Woodline Partners
California
-$11.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
FDCDDQ
76
Federation des caisses Desjardins du Quebec
Quebec, Canada
$2.06M +$469K +7,200 +30%
IIM
77
INTECH Investment Management
Florida
$1.76M +$1.01M +15,447 +135%
WCM
78
Wedge Capital Management
North Carolina
$1.58M -$977 -15 -0.1%
MAM
79
Martingale Asset Management
Massachusetts
$1.57M +$32.5K +499 +2%
Amundi
80
Amundi
France
$1.54M +$1.54M +23,633 New
DekaBank Deutsche Girozentrale
81
DekaBank Deutsche Girozentrale
Germany
$1.49M – – –
Susquehanna International Group
82
Susquehanna International Group
Pennsylvania
$1.46M -$1.67M -25,721 -54%
New York State Teachers Retirement System (NYSTRS)
83
New York State Teachers Retirement System (NYSTRS)
New York
$1.45M – – –
JCIA
84
Jackson Creek Investment Advisors
Colorado
$1.39M +$179K +2,747 +15%
AllianceBernstein
85
AllianceBernstein
Tennessee
$1.31M – – –
ECM
86
ExodusPoint Capital Management
New York
$1.28M -$2.24M -34,345 -64%
Citigroup
87
Citigroup
New York
$1.28M -$574K -8,813 -31%
American Century Companies
88
American Century Companies
Missouri
$1.27M -$416K -6,384 -25%
Canada Life
89
Canada Life
Manitoba, Canada
$1.27M +$12.9K +198 +1%
Natixis Advisors
90
Natixis Advisors
Massachusetts
$1.23M +$10.8K +166 +0.9%
AQR Capital Management
91
AQR Capital Management
Connecticut
$1.21M +$295K +4,535 +32%
Prudential Financial
92
Prudential Financial
New Jersey
$1.18M +$109K +1,680 +10%
LCM
93
Legato Capital Management
California
$1.18M – – –
WAM
94
Wakefield Asset Management
Colorado
$1.12M -$9.12K -140 -0.8%
Brown Advisory
95
Brown Advisory
Maryland
$1.11M +$1.11K +17 +0.1%
DB
96
Danske Bank
Denmark
$1.08M -$725K -11,133 -40%
VEA
97
Virtus ETF Advisers
New York
$1.04M +$139K +2,135 +16%
Franklin Resources
98
Franklin Resources
California
$1.02M +$229K +3,514 +29%
California State Teachers Retirement System (CalSTRS)
99
California State Teachers Retirement System (CalSTRS)
California
$1.02M -$14.7K -225 -1%
VOYA Investment Management
100
VOYA Investment Management
Georgia
$972K +$388K +5,962 +67%
2 3
4
5 6

ANIP Hedge Fund Activity: Q2 2025 in Review

232 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in ANI Pharmaceuticals (ANIP) for Q2 2025, worth a combined $1.29B — down 4.7% from $1.35B a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new ANIP positions and 25 closed out — a net gain of 3 holders — while 89 added to existing stakes and 76 trimmed.

The largest buyer was Nuveen, adding an estimated $21M. The largest seller was Goldman Sachs, cutting an estimated $27.7M.

  • 232 institutional investors held ANI Pharmaceuticals (ANIP) as of Q2 2025, up from 230 in Q1 2025.
  • Funds reported $1.29B of ANI Pharmaceuticals stock for Q2 2025, down 4.7% quarter-over-quarter.
  • 28 funds opened new ANI Pharmaceuticals positions in Q2 2025 and 25 closed out, a net change of +3 holders.
  • The largest ANI Pharmaceuticals buyer in Q2 2025 was Nuveen, an estimated $21M added.
  • The largest ANI Pharmaceuticals seller in Q2 2025 was Goldman Sachs, an estimated $27.7M sold.

Based on aggregated 13F filings for Q2 2025.